+ND Capital — Full Portfolio
40 tracked investments · listed companies and verified rows first
AstraZeneca develops and markets pharmaceutical products, vaccines, and biologics across oncology, cardiovascular disease, respiratory and immunology, and rare disease areas, serving patients and healthcare providers globally.
Cambridge, GB
Co-investorsvenBio Partners
Cartesian Therapeutics is a clinical-stage biotechnology company developing mRNA-based cell therapies aimed at treating autoimmune diseases.
BiotechHealthtechWatertown, US
Metin Kurtoglu(Executive Officer)Omid Farokhzad(Director)Chris Jewell(Executive Officer)inCarsten Brunn(President, CEO & Chairman of the Board)inEmily English(Executive Officer)inBlaine Davis(Executive Officer)in
Co-investorsK2 HealthVenturesMaryland TEDCOSchooner CapitalTEDCOPolaris PartnersRUSNANO
Twist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals.
BiotechDeep TechSemiconductorsSouth San Francisco, US
William Charles Banyai(Executive Officer, Director, Promoter)Bill James Peck(Executive Officer, Promoter)Emily Leproust(Founder)inEmily M. Leproust(Chief Executive Officer and Chair of the Board)inPatrick Finn(President and Chief Operating Officer)inAdam Laponis(Chief Financial Officer)in
Co-investors3E Bioventures CapitalARCH Venture PartnersAsset Management CompanyBay City CapitalBlack Opal VenturesDentsu Ventures+8 more
Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.
BiotechDeep TechHealthtech
Donald Ingber(Scientific Founder, Board Member, Scientific Advisory Board Chairman)inDaniel Levner(Co-Founder & CTO)inJim Corbett(CEO, Board Member)inLorna Ewart(Chief Scientific Officer)in
Co-investorsNorthpond VenturesAlwyn CapitalFourth RealmStray Dog CapitalOS FundStarlight Ventures
Notify develops pharmaceutical treatments for women with diminished ovarian reserves by targeting dormant follicle activation through NRF2 pathway modulation.
BiotechDigital HealthFemTechHealthtechMedical DevicesAarhus, DK
Karin Lykke-Hartmann(Chief Executive Officer & Founder)
PulseSight Therapeutics develops non-viral, plasmid-based gene therapies delivered via a proprietary electro-transfection system into the ciliary muscle to treat severe retinal diseases causing blindness.
BiotechHealthtechMedical Devices
Co-investorsPureos Bioventures
Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.
BiotechHealthtechLongevityMedical DevicesLausanne, CH
Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)
Co-investorsDolby Family VenturesApollo Health Ventures
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)in
Co-investorsARCH Venture PartnersForbionVenrockFast Track InitiativeNextech InvestNovalis LifeSciences+2 more
BiotechNew York, US
Masoud Tavazoie(Chief Scientific Officer)David Darst(Chief Operating Officer)Isabel Kurth(Vice President - Research)
BoardShahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)
Board seatPeter Van Vlasselaer· per SEC Form D · $11M raise · filed Feb 2021
Co-investorsOceanpine CapitalSofinnova Partners
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases.
BiotechHealthtechMedical Devices
Co-investorsArtis Ventures
Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy.
BiotechLongevityWellness & FitnessLausanne, CH
Co-investorsBold Capital Partners
Arc Therapeutics is a stealth-stage biopharmaceutical company developing medicines for central nervous system (CNS) conditions with high unmet medical needs.
BiotechHealthtech
Co-investorsV-Bio Ventures
Constructive Bio is a biotechnology company that rewrites the genetic code to give cells access to non-canonical amino acid building blocks, expanding the range of proteins that can be designed, engineered, and manufactured.
BiotechDeep TechNew Materials
Jason Chin(Professor)
Co-investorsAmadeus Capital PartnersFine Structures VenturesGENERAL INCEPTIONLongeVCOMX VenturesPaladin Capital Group+3 more
Crocus Technology, now part of Allegro MicroSystems, develops XtremeSense TMR (Tunnel Magnetoresistance) magnetic sensing technology used in integrated current and position sensor ICs.
Co-investorsVentechVentech ChinaCEA InvestissementSofinnova Ventures
Cytoki is a biotech company developing IL-22-based therapeutics using lipidation technology to treat metabolic diseases such as obesity and type 2 diabetes, as well as conditions involving epithelial injury like inflammatory bowel disease.
BiotechHealthtechVærløse, DK
Rasmus Jorgensen(CEO & Founder)
Co-investorsYsios CapitalSeventure Partners
Euphrates Vascular develops the Pulse NanoMED System, a nanoscale interventional medical device that uses magnetically guided iron-oxide nanoparticles to reach and disrupt distal vascular occlusions beyond the reach of wires and catheters.
BiotechHealthtechMedical DevicesSt. Louis, US
Troy Long(Executive Officer)Jeffrey Blair(Director)Tim Blair(Executive Officer)inEric Moessinger(Director)Robert Mitchell(Director)Thomas Hillman(Director)
Co-investorsMissouri Technology CorporationOSF VenturesView VenturesCultivation Capital
H55 develops certified electric propulsion systems and energy storage solutions for aviation, enabling aircraft manufacturers to transition to electric flight.
CleantechEnergyHardwareMobility & TransportationSion, CH
André Borschberg(Co-Founder and Executive Chairman)in
Co-investorsACE & CompanyTippet Venture Partners (Gp), Llc
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in
Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures4see VenturesHumboldt
BiotechBoulder, US
Michael Graige(Executive Officer)Ron McGrath(Executive Officer)Sri Kosaraju(Executive Officer, Director)Dianna L. DeVore(Executive Officer)
BoardRoger Wyse(Director)inBryan Roberts(Director)in
Co-investorsForesite CapitaliGlobe PartnersKorysOak HC/FTOMX VenturesPaladin Capital Group+3 more
Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.
BiotechDeep TechHealthtech
Co-investorsIllumina VenturesLongwall Venture Partners LLPM VenturesOMX VenturesARCH Venture Partners
Manus Bio uses industrial biotechnology and engineered microbial cell factories to produce "BioAlternatives" — sustainable versions of molecules normally sourced from petrochemicals, agriculture, or animal husbandry — and offers a scale-up platform covering cell factory design through biomanufacturing.
BiotechFoodTechNew MaterialsAugusta, US
Ajikumar Parayil(Executive Officer, Director)inAji Parayil(Co-founder)inGreg Stephanopoulos(Co-founder)
BoardJason Whaley(Director)inCarsten Boers(Director)inRichard Goldstein(Director)
Co-investorsCivilization Ventures Management, LlcEnergy Impact PartnersLiebenthal VenturesNelstone VenturesNXT VenturesPrefix Capital+2 more
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
Co-investorsARCH Venture PartnersBluebird VenturesSutter Hill Ventures
Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesEmeryville, US
Sri Kosuri(Co-founder)inRamsey Homsany(Founder)in
Co-investorsAndreessen Horowitz8VCCarbon SiliconCatalio Capital Management, LPFifty YearsFlucas Ventures+7 more
Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome.
BiotechDigital HealthHealthtechMedical DevicesCalifornia, US
Jeroen(Co-founder and President)Ivan Dimov(Executive Officer, Director)inNathaniel Fernhoff(Executive Officer, Director)in
BoardAlex Kolicich(Director)inJonathan MacQuitty(Director)in
Co-investors8VCDCVC (Data Collective)Felicis VenturesLightspeed Venture PartnersSeraph Group
Partillion generates cell-cell interaction data using Nanovials that co-localize cells in defined microenvironments to measure signaling, activation, binding, and other responses, with live-cell recovery via standard flow cytometry.
AI & Machine LearningBiotechDeep TechLos Angeles, US
Dino Di Carlo(Director)inJoe de Rutte(Founder)inEric Moessinger(Director)in
BoardPaul Conley(Director)in
Co-investorsGENERAL INCEPTIONPaladin Capital GroupVertical Venture Partners
Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Justin Farlow(Co-founder)inColin Farlow(Co-founder)Eric Moessinger(Director)in
Co-investors8VC
SiMa.ai designs silicon and software to enable machine learning inference at the edge, deployed in industrial, automotive, and autonomous systems rather than cloud environments.
AI & Machine LearningDeep TechHardwareSemiconductorsSan Jose, US
Krishna Rangasayee(Founder & CEO)in
Co-investorsAmplify PartnersWing
SPARK Microsystems develops ultra-wideband (UWB) wireless connectivity technology for applications including Physical AI, XR, audio, gaming, human interface, and IoT devices.
Deep TechHardwareIoTSemiconductors
Co-investorsSilicon CatalystCycle Capital
Syndex develops mcPCR (methyl copying PCR), a proprietary platform technology that amplifies DNA while preserving methylation patterns, addressing the challenge of low DNA levels in clinical samples.
BiotechDeep TechMedical DevicesSanta Monica, US
Geoff Smith(Founder & CEO)inJason Betley(Chief Product Officer)in
Co-investorsOMX VenturesARCH Venture Partners
BiotechWatertown, US
Omid Farokhzad(Director)inRobert S. Langer, Jr.(Director)Omid C. Farokhzad(Director)inRobert S. Langer(Director)Andrew J. Fromkin(Executive Officer, Director)Leila Alland(Executive Officer)in
Co-investorsKendall Capital PartnersNew Enterprise Associates (NEA)
Visby offers an FDA-authorized at-home PCR test kit for women's sexual health that detects chlamydia, gonorrhea, and trichomoniasis from a single swab, delivering private results via a mobile app in about 30 minutes with included same-day telehealth for positive results.
ConsumerDigital HealthFemTechHealthtechMedical DevicesTokyo, US
Adam de la Zerda(Founder)in
Co-investors1809 CapitalAmplify PartnersArtiman VenturesG Vision CapitalKhosla VenturesSeraph Group+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Blade TherapeuticsAmphivena TherapeuticsARMO BioSciencesBIND TherapeuticsNatron EnergySelecta BiosciencesSQZ Biotech
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.